ATM mediates the downregulation of SLC7A11 after radiotherapy, resulting in ferroptosis; this anti-neoplastic effect of radiotherapy is enhanced by the combination of immune checkpoint inhibitors, e.g., anti-PD-L1 or anti-CTLA4 antibodies, in tumor models [116]. Here, ATM is linked to neoplasm.